Miliary Neonatal Hemangiomatosis with Fulminant Heart Failure and Cardiac Septal Hypertrophy in Two Infants

Abstract:  Miliary neonatal hemangiomatosis is a rare, life‐threatening condition associated with cutaneous and multiorgan involvement. We report two infants with this condition who had fulminant cardiac failure and cardiac septal hypertrophy. The first was a 5‐day‐old boy who presented with increasing numbers of cutaneous hemangiomata associated with worsening cardiac failure. Magnetic resonance imaging (MRI) showed extensive hepatic hemangioma. Despite treatment with systemic corticosteroids and subcutaneous interferon alfa‐2b his disease progressed. Hepatic artery embolization was unsuccessful. The infant died of congestive cardiac failure at 6 weeks of age. Postmortem examination showed a massively enlarged cardiac interventricular septum and biventricular hypertrophy. The second patient was a 1‐week‐old girl who also had cutaneous hemangioma and cardiac decompensation. MRI showed extensive intrahepatic involvement. She was treated early with corticosteroids and interferon α, which resulted in involution of the cutaneous and hepatic lesions. Cardiac septal hypertrophy did not persist at late follow‐up, and the association of miliary neonatal hemangiomatosis and cardiac septal hypertrophy has not yet been established.

[1]  M. Nagano,et al.  Mechanical catecholamine responsiveness and myosin isoenzyme pattern of pressure-overloaded rat ventricular myocardium , 1987, Basic Research in Cardiology.

[2]  H. Halliday The effect of postnatal steroids on growth and development , 2001, Journal of perinatal medicine.

[3]  G. Tortorolo,et al.  Effect on Growth of Two Different Dexamethasone Courses for Preterm Infants at Risk of Chronic Lung Disease , 1999, Pharmacology.

[4]  M. Mikati,et al.  Transient Hypertrophic Cardiomyopathy in the Newborn Following Multiple Doses of Antenatal Corticosteroids , 1999, American journal of perinatology.

[5]  J. Mulliken,et al.  Spastic Diplegia as a Complication of Interferon Alfa‐2a Treatment of Hemangiomas of Infancy , 1998, The Journal of pediatrics.

[6]  J. Masferrer,et al.  Treatment of Life-Threatening Infantile Hemangiomas with Vincristine , 1995 .

[7]  G. Baumbach,et al.  Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload. , 1994, The American journal of physiology.

[8]  J. Mulliken,et al.  The Current Management of Vascular Birthmarks , 1993, Pediatric dermatology.

[9]  J. Covell,et al.  Collagen characterization in volume-overload- and pressure-overload-induced cardiac hypertrophy in minipigs. , 1993, The American journal of physiology.

[10]  J. N. Schullinger Interferon alfa-2a therapy for life-threatening hemangiomas of infancy , 1992 .

[11]  J. Mulliken,et al.  Interferon alfa‐2a therapy for life‐threatening hemangiomas of infancy , 1992, The New England journal of medicine.

[12]  P. Frommelt,et al.  Effect of increased pressure on ventricular growth in stage 21 chick embryos. , 1989, The American journal of physiology.

[13]  M. Nagano,et al.  Myocardial contractility and left ventricular myosin isoenzyme pattern in cardiac hypertrophy due to chronic volume overload. , 1987, Basic Research in Cardiology.

[14]  P. Burrows,et al.  Diffuse hepatic hemangiomas: percutaneous transcatheter embolization with detachable silicone balloons. , 1985, Radiology.

[15]  J. Wolf,et al.  Benign neonatal hemangiomatosis. , 1981, Journal of the American Academy of Dermatology.

[16]  B. Berman,et al.  Concurrent cutaneous and hepatic hemangiomata in infancy: report of a case and a review of the literature. , 1978, The Journal of dermatologic surgery and oncology.

[17]  Fredy Alexander,et al.  Diffuse neonatal hemangiomatosis. , 1970, Pediatrics.

[18]  A. G. Cooper,et al.  MULTIPLE HEMANGIOMAS IN AN INFANT WITH CARDIAC HYPERTROPHY. POSTMORTEM ANGIOGRAPHIC DEMONSTRATION OF THE ARTERIOVENOUS FISTULAE. , 1965, Pediatrics.